Effect of short-term cardiac function changes after cardiac resynchronization therapy on long-term prognosis in heart failure patients with and without diabetes

被引:1
作者
Yu, Yu [1 ]
Ding, Ligang [1 ]
Huang, Hao [1 ]
Cheng, Sijing [1 ]
Deng, Yu [1 ]
Cai, Chi [1 ]
Gu, Min [1 ]
Chen, Xuhua [1 ]
Niu, Hongxia [1 ]
Hua, Wei [2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp,Cardiac Arrhythmia Ctr, Natl Ctr Cardiovasc Dis,Dept Cardiol, State Key Lab Cardiovasc Dis,Dept Cardiol, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp,Cardiac Arrhythmia Ctr, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Cardiol, 167 Bei Li Shi Rd, Beijing 100037, Peoples R China
关键词
all-cause mortality; cardiac function; cardiac resynchronization therapy; diabetes; heart failure; OXIDATIVE STRESS; DYSFUNCTION; OUTCOMES; DEFIBRILLATOR; HYPERGLYCEMIA; MELLITUS; IMPACT;
D O I
10.1177/20406223231223285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background:The relationship between short-term cardiac function changes and long-term outcomes in heart failure (HF) patients undergoing cardiac resynchronization therapy (CRT) remains uncertain, especially when stratified by diabetes status.Objectives:This study aims to assess the association between short-term cardiac function changes and outcomes such as all-cause mortality and HF hospitalization in patients undergoing CRT, stratified by diabetes status.Design:This is a cohort longitudinal retrospective study.Methods:A total of 666 HF patients, treated with CRT between March 2007 and March 2019, were included in this study. Among them, 166 patients (24.9%) were diagnosed with diabetes. Cardiac function was assessed at baseline and again at 6 months, incorporating evaluations of left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD), left atrial diameter (LAD), N-terminal prohormone of brain natriuretic peptide (NT-proBNP), and QRS duration. The QRS duration represents the time required for a stimulus to spread through the ventricles (ventricular depolarization). The primary endpoints of the study were all-cause mortality and HF-related hospitalization.Results:During a median follow-up of 2.51 years, 172 (25.8%) patients died and 197 (29.6%) were hospitalized for HF. Changes in LVEF, LVEDD, and LAD within 6 months had similar effects on adverse outcomes in both diabetic and nondiabetic patients. However, the presence of diabetes significantly modified the association between changes in NT-proBNP and QRS duration and adverse outcomes. Short-term changes in NT-proBNP and QRS duration were positively associated with all-cause mortality and HF hospitalization in patients without diabetes. However, the relationship between short-term changes in NT-proBNP and QRS duration and adverse outcomes was non-linear in diabetic patients.Conclusion:Improvement of cardiac function after CRT implantation can reduce long-term risk of all-cause mortality and HF hospitalization in HF patients. However, the presence of diabetes may affect the association between short-term changes in NT-proBNP and QRS duration and adverse outcomes.
引用
收藏
页数:14
相关论文
共 45 条
  • [1] Left atrial size - Physiologic determinants and clinical applications
    Abhayaratna, Walter P.
    Seward, James B.
    Appleton, Christopher P.
    Douglas, Pamela S.
    Oh, Jae K.
    Tajik, A. Jamil
    Tsang, Teresa S. M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) : 2357 - 2363
  • [2] World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20): : 2191 - 2194
  • [3] Utility of Equilibrium Radionuclide Angiogram-Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
    Badhwar, Nitish
    James, Jameze
    Hoffmayer, Kurt S.
    O'Connell, John W.
    Green, Deanna
    De Marco, Teresa
    Botvinick, Elias H.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (12) : 1880 - 1886
  • [4] Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction
    Breathett, Khadijah
    Allen, Larry A.
    Udelson, James
    Davis, Gordon
    Bristow, Michael
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (10)
  • [5] Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    Bristow, MR
    Saxon, LA
    Boehmer, J
    Krueger, S
    Kass, DA
    De Marco, T
    Carson, P
    DiCarlo, L
    DeMets, D
    White, BG
    DeVries, DW
    Feldman, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2140 - 2150
  • [6] Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
    Ceriello, Antonio
    Novials, Anna
    Ortega, Emilio
    Canivell, Silvia
    La Sala, Lucia
    Pujadas, Gemma
    Esposito, Katherine
    Giugliano, Dario
    Genovese, Stefano
    [J]. DIABETES CARE, 2013, 36 (08) : 2346 - 2350
  • [7] The effect of cardiac resynchronization on morbidity and mortality in heart failure
    Cleland, JGF
    Daubert, J
    Erdmann, E
    Freemantle, N
    Gras, D
    Kappenberger, L
    Tavazzi, L
    Cleland, JGF
    Daubert, JC
    Erdmann, E
    Gras, D
    Kappenberger, L
    Klein, W
    Tavazzi, L
    Poole-Wilson, PA
    Rydén, L
    Wedel, H
    Wellens, HJJ
    Uretsky, B
    Thygesen, K
    Böcker, D
    Marijianowski, MMH
    Freemantle, N
    Calvert, MJ
    Christ, G
    Fruhwald, F
    Hofmann, R
    Krypta, A
    Leisch, F
    Pacher, R
    Rauscha, F
    Tavernier, R
    Thomsen, PEB
    Boesgaard, S
    Eiskjær, H
    Esperen, GT
    Haarbo, J
    Hagemann, A
    Korup, E
    Moller, M
    Mortensen, P
    Sogaard, P
    Vesterlund, T
    Huikuri, H
    Niemelä, KI
    Toivonen, L
    Bauer, F
    Cohen-Solal, A
    Crocq, C
    Djiane, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) : 1539 - 1549
  • [8] Avoiding non-responders to cardiac resynchronization therapy: a practical guide
    Daubert, Claude
    Behar, Nathalie
    Martins, Raphael P.
    Mabo, Philippe
    Leclercq, Christophe
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (19) : 1463 - 1472C
  • [9] Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
    Dunlay, Shannon M.
    Givertz, Michael M.
    Aguilar, David
    Allen, Larry A.
    Chan, Michael
    Desai, Akshay S.
    Deswal, Anita
    Dickson, Victoria Vaughan
    Kosiborod, Mikhail N.
    Lekavich, Carolyn L.
    McCoy, Rozalina G.
    Mentz, Robert J.
    Pina, Ileana L.
    [J]. CIRCULATION, 2019, 140 (07) : E294 - E324
  • [10] Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure
    Echouffo-Tcheugui, Justin B.
    Masoudi, Frederick A.
    Bao, Haikun
    Spatz, Erica S.
    Fonarow, Gregg C.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (08)